Data showed that the primary endpoint of recurrence-free survival (RFS) met the pre-specified futility criteria
Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
Investing in Malaysia's largest clinic operator to expand the healthcare business
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
2024 full-year revenue guidance raised by US$ 2 billion
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Subscribe To Our Newsletter & Stay Updated
